FDA Approves Topical PDE4-Inhibitor Roflumilast for Psoriasis ...Middle East

Medscape - News
A topical formulation of a PDE4 inhibitor approved for treating COPD has been approved for treatment of plaque psoriasis. FDA Approvals

Hence then, the article about fda approves topical pde4 inhibitor roflumilast for psoriasis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Topical PDE4-Inhibitor Roflumilast for Psoriasis )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News